Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Urinary Tract Calculi VI: Surgical Management01:25

Urinary Tract Calculi VI: Surgical Management

Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs like...
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Etiology of Hunner Lesions: Linking Immune Dysregulation and Chronic Inflammation in Interstitial Cystitis/Bladder Pain Syndrome.

International urogynecology journal·2026
Same author

Characterization of KRAS<sup>G12C</sup> inhibitor olomorasib single-agent and combination with activity in KRAS<sup>G12C</sup>-mutant models.

Nature communications·2026
Same author

Lamina Propria Collagen Architecture in Interstitial Cystitis/Bladder Pain Syndrome.

The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society·2026
Same author

Correlates of Positive Response to Therapeutic Hydrodistension in Interstitial Cystitis/Bladder Pain Syndrome.

Neurourology and urodynamics·2025
Same author

Patient Related Outcomes for Interstitial Cystitis/Bladder Pain Syndrome Recommendations for Clinical Trials and General Urology Practice.

Neurourology and urodynamics·2025
Same author

Re: Pentosan polysulfate and a pigmentary maculopathy: causation versus correlation?

The Canadian journal of urology·2023

Related Experiment Video

Updated: Jul 19, 2026

Urinary Bladder Distention Evoked Visceromotor Responses as a Model for Bladder Pain in Mice
11:46

Urinary Bladder Distention Evoked Visceromotor Responses as a Model for Bladder Pain in Mice

Published on: April 27, 2014

Treatment approaches for interstitial cystitis: multimodality therapy.

Robert J Evans

    Reviews in Urology
    |September 21, 2006
    PubMed
    Summary

    Interstitial cystitis (IC), a condition causing pelvic pain, urgency, and frequency, is increasingly common. Multimodality therapy, addressing multiple disease components, shows greater effectiveness than single treatments for IC.

    Area of Science:

    • Urology
    • Immunology
    • Pathophysiology

    Background:

    • Interstitial cystitis (IC) is a prevalent condition marked by urinary urgency, frequency, and pelvic pain.
    • The exact causes of IC remain unclear, suggesting a multifactorial etiology.
    • Current understanding points to a complex interplay of factors contributing to IC development.

    Purpose of the Study:

    • To present a proposed pathophysiological model for interstitial cystitis.
    • To outline a cascade of events including epithelial dysfunction, mast cell activation, and neurogenic inflammation.
    • To introduce multimodality therapy regimens based on this pathophysiological model.

    Main Methods:

    • Development of a theoretical model for IC pathophysiology.
    • Design of therapeutic strategies targeting multiple components of the proposed cascade.

    Related Experiment Videos

    Last Updated: Jul 19, 2026

    Urinary Bladder Distention Evoked Visceromotor Responses as a Model for Bladder Pain in Mice
    11:46

    Urinary Bladder Distention Evoked Visceromotor Responses as a Model for Bladder Pain in Mice

    Published on: April 27, 2014

  • Comparative assessment of multimodality therapy versus single-agent treatments.

    • Main Results:

    • A pathophysiological cascade model for IC involving epithelial dysfunction, mast cell activation, and neurogenic inflammation was proposed.
    • Multimodality therapy regimens were developed to address all facets of this cascade.
    • Multimodality therapy demonstrated superior efficacy compared to single therapeutic agents in managing IC.

    Conclusions:

    • The proposed pathophysiological model provides a framework for understanding interstitial cystitis.
    • Multimodality therapy, targeting the integrated cascade, offers a more effective treatment approach for IC.
    • This approach holds promise for improving patient outcomes in interstitial cystitis management.